240 related articles for article (PubMed ID: 26215971)
21. A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease.
Brinkrolf P; Landmeier S; Altvater B; Chen C; Pscherer S; Rosemann A; Ranft A; Dirksen U; Juergens H; Rossig C
Int J Cancer; 2009 Aug; 125(4):879-86. PubMed ID: 19480009
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.
Griesinger AM; Josephson RJ; Donson AM; Mulcahy Levy JM; Amani V; Birks DK; Hoffman LM; Furtek SL; Reigan P; Handler MH; Vibhakar R; Foreman NK
Cancer Immunol Res; 2015 Oct; 3(10):1165-74. PubMed ID: 25968456
[TBL] [Abstract][Full Text] [Related]
23. Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells.
Shelake S; Sankpal UT; Eslin D; Bowman WP; Simecka JW; Raut S; Ray A; Basha R
Apoptosis; 2019 Feb; 24(1-2):21-32. PubMed ID: 30610505
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.
Chalaris A; Rabe B; Paliga K; Lange H; Laskay T; Fielding CA; Jones SA; Rose-John S; Scheller J
Blood; 2007 Sep; 110(6):1748-55. PubMed ID: 17567983
[TBL] [Abstract][Full Text] [Related]
26. RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein.
Hernandez-Muñoz I; Figuerola E; Sanchez-Molina S; Rodriguez E; Fernández-Mariño AI; Pardo-Pastor C; Bahamonde MI; Fernández-Fernández JM; García-Domínguez DJ; Hontecillas-Prieto L; Lavarino C; Carcaboso AM; de Torres C; Tirado OM; de Alava E; Mora J
Oncotarget; 2016 Jul; 7(29):46283-46300. PubMed ID: 27317769
[TBL] [Abstract][Full Text] [Related]
27. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway.
Xue H; Yuan G; Guo X; Liu Q; Zhang J; Gao X; Guo X; Xu S; Li T; Shao Q; Yan S; Li G
Autophagy; 2016 Jul; 12(7):1129-52. PubMed ID: 27163161
[TBL] [Abstract][Full Text] [Related]
28. The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
von Heyking K; Calzada-Wack J; Göllner S; Neff F; Schmidt O; Hensel T; Schirmer D; Fasan A; Esposito I; Müller-Tidow C; Sorensen PH; Burdach S; Richter GHS
Mol Oncol; 2017 Sep; 11(9):1288-1301. PubMed ID: 28319320
[TBL] [Abstract][Full Text] [Related]
29. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of miR‑199b‑5p inhibits Ewing's sarcoma cell lines by targeting CCNL1.
Li W; Li Y; Guo J; Pan H; Zhang Y; Wang X
Mol Med Rep; 2015 Sep; 12(3):3359-3364. PubMed ID: 26043836
[TBL] [Abstract][Full Text] [Related]
31. The interleukin-6/interleukin-6-receptor system is activated in donor hearts.
Plenz G; Eschert H; Erren M; Wichter T; Böhm M; Flesch M; Scheld HH; Deng MC
J Am Coll Cardiol; 2002 May; 39(9):1508-12. PubMed ID: 11985915
[TBL] [Abstract][Full Text] [Related]
32. A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.
Yu SH; Zheng Q; Esopi D; Macgregor-Das A; Luo J; Antonarakis ES; Drake CG; Vessella R; Morrissey C; De Marzo AM; Sfanos KS
Cancer Immunol Res; 2015 Oct; 3(10):1175-84. PubMed ID: 26048576
[TBL] [Abstract][Full Text] [Related]
33. Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma.
Zhou Z; Guan H; Duan X; Kleinerman ES
Cancer; 2005 Oct; 104(8):1713-20. PubMed ID: 16121404
[TBL] [Abstract][Full Text] [Related]
34. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract][Full Text] [Related]
35. The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.
von Heyking K; Roth L; Ertl M; Schmidt O; Calzada-Wack J; Neff F; Lawlor ER; Burdach S; Richter GH
Oncotarget; 2016 Jul; 7(27):41767-41780. PubMed ID: 27363011
[TBL] [Abstract][Full Text] [Related]
36. Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis.
Méndez-Clemente A; Bravo-Cuellar A; González-Ochoa S; Santiago-Mercado M; Palafox-Mariscal L; Jave-Suárez L; Solorzano-Ibarra F; Villaseñor-García M; Ortiz-Lazareno P; Hernández-Flores G
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703345
[TBL] [Abstract][Full Text] [Related]
37. Let-7a suppresses macrophage infiltrations and malignant phenotype of Ewing sarcoma via STAT3/NF-κB positive regulatory circuit.
Zhang Z; Li Y; Huang L; Xiao Q; Chen X; Zhong J; Chen Y; Yang D; Han Z; Shu Y; Dai M; Cao K
Cancer Lett; 2016 May; 374(2):192-201. PubMed ID: 26902422
[TBL] [Abstract][Full Text] [Related]
38. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
39. Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.
Shi X; Wu Y; Tang L; Ni H; Xu Y
Aging (Albany NY); 2023 Mar; 15(6):2321-2346. PubMed ID: 36988561
[TBL] [Abstract][Full Text] [Related]
40. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
